Injective Protocol tests test EVM compatibility for Ethereum Smart Contracts to run natively. After SBET and stock tokenization, is Inj Crypto ready for 130% meetings?

Cryptocurrency prices are stable and flat-ring over the weekend, but appear strongly and close over $4 trillion. Bitcoin has a dominance of less than 60%, but Ethereum has gained traction, and now The best cipher to buy. The Altcoin season is imminent as hundreds of millions of dollars are poured into the second most precious coin.

Discovered: 20+ Next Cryptographs to explode in 2025

Is Inj Crypto ready for 130% spikes?

Ahead of this expected surge in Altcoin prices, Injective has made headlines over the past few days. This positive news flow is solid Inj (no data) Crypto price.

As of July 28th, Inj has remained stable, up nearly 20% since Friday, July 25th. Prices have risen over the weekend, putting the Bulls in a strong position to reverse losses from last week and break $16 with a bullish breakout formation.

If the buyer is successful, if the losses are completely reversed from July 23rd, it could set a strong foundation to return to its December 2024 high of around $35. If that happens, Inj Crypto is in it Next 1000X Cryptos Consider it.

From the current rate, this represents an increase of around 130%. This is a major boost to INJ, where developers are actively building and improving the platform offering.

Technically, the coin has moved sideways after a surge since April 2025. Over $17 this week, buyers will need to push the tailbone they need, print highs from H1 2025, or reverse the loss. In that case, Inj will expand to $35 and you can ride the Defi Wave.

Discover: Best New Cryptocurrencies to Invest in 2025

Release of EVM environments on Testnet

Last week, Injective developers announced a pivotal step in their quest to create not only high-performance products, but also products that can interoperate with the first smart contract platform.

In the post, they said they successfully tested Injective’s EVM environment to allow Ethereum-compatible smart contracts to run natively on that rail once deployed to the mainnet.

BREAKING NEWS: The Injective EVM mainnet has been successfully achieved internally.

— Injective (@injective) July 27, 2025

This deployment means that the injection eliminates the need for cross-chain bridges or roll-ups, and Defi protocols that are attempting to run on Ethereum take advantage of low cost and high scalability to work simultaneously with neglect.

An EVM environment aimed at integrating 320-800 TPS provided in a simulated environment in the mainnet during testing. However, it could potentially process up to 12,500 transactions per second, or up to four times faster than other EVM-based solutions.

This test and planned mainnet launch complement the ignored multi-vertle machine token standard (MTS), reducing duplication and improving complexity.

Injective leads RWA tokenized charge

Injective Protocol launched SBET stock on the mainnet after releasing its first Chain Digital Assets Treasury (DAT) last week.

Injective has launched the first ever onchain Digital Asset Treasury (DAT).$SBET, the largest DAT for $ETH is live onchain, giving Injective users 24/7 access with leverage to one of the hottest financial products yet.

The future of global markets starts on $INJ pic.twitter.com/OXW6PuLkjd

— Injective (@injective) July 24, 2025

Through DAT, Injective Protocol will tokenize the SBET stock and public company Sharplink will reflect MicroStrategy’s plans and launch Ethereum Treasury.

SBET Stock Tokenization converts Sharplink’s static ETH holdings into tradable assets 24/7, 7 days a year, generating yields; It will be used As collateral for Defi protocols supported via Injective Protocol Iassets.

Injective, Bondi Finance also introduced tokenized bonds as reject-centric platforms move more and more towards real-world assets.

https://www.youtube.com/watch?v=3wtvkulzobe

Bondi Finance allows users to merge tokens during the funding stage before trading in the secondary market. This makes corporate bonds more accessible to retailers and institutional investors.

Tokenized corporate bonds can be integrated into the Defi protocol or used in derivatives to increase their usefulness and liquidity.

Discover: 10 high-risk, high-reward codes for 2025

Why you can trust 99 Bitcoin?

Over 10 years

Founded in 2013, 99 Bitcoin team members have been experts in crypto since the early days of Bitcoin.

90 hours+

Weekly research

100k+

Monthly Readers

50+

Expert Contributors

2000+

Crypto project reviewed

Follow 99 Bitcoin on Google News Feed

Provide the latest updates, trends and insights directly to your fingertips. Subscribe now!

Subscribe now

Injective (INJ) could be preparing for another retest of the $10 resistance as its price attempts to confirm a key support level. Some analysts suggest that the cryptocurrency could be preparing for a breakout and a massive bullish reversal.

Related Reading

Injective Eyes $10 Retest

Over the past month, Injective has surged around 43% from its 18-month low registered on April 7. During last month’s recovery, the cryptocurrency pumped from the $6.34 low to the $10 barrier, hitting a six-week high of $10.63 before retracing.

INJ has been in a downtrend since hitting its Q4 high of $35.26, retracing nearly 75% in the last six months. Analyst Crypto Rand noted that the token has attempted to break out of the downtrend but has faced strong resistance around the $9.5-$10 range.

Following its recent jump, Injective got rejected from this range, with some market watchers suggesting that it could retest the $9-$9.20 levels as support before the next breakout attempt.

Amid the weekend retrace, INJ’s price has touched these levels, trading between the $9.00-$9.40 and briefly falling to $8.90 before bouncing. After the 4.8% drop, the cryptocurrency is attempting to confirm this level as support, which could help Injective gain strength for another push above the key zone and toward the $11-$12 resistance.

Crypto Rand noted that a breakout of the “$10 range would trigger the bullish reversal,” which could also propel the token toward the $14 barrier, lost in early March. Notably, this level has been a key horizontal level since the November post-election pump, serving as a crucial support and resistance.

INJ Ready For A Breakout?

Meanwhile, analyst Sjuul from AltCryptoGems highlighted a massive, inverse Head and Shoulders pattern on INJ’s chart, noting that investors should pay attention as “this is one of the strongest reversal patterns.” This formation is a bullish reversal chart that suggests a potential shift from a downtrend to an uptrend.

According to the chart, the cryptocurrency has formed this setup over the past two months, with the neckline sitting around the $10.30 resistance level. A breakout from the neckline could trigger a significant surge toward the $14 mark.

Analyst Lennaert affirmed that INJ “feels like an absolute steal” at its current range, as he considers that the cryptocurrency is likely not going lower than the 2023 key support at around $5.5.

The analyst suggested that if momentum flips to altcoins, INJ’s price “will be back at the highs in no time,” adding that it has “one of the strongest fundamentals of all projects out there.”

Related Reading

Notably, the project announced that “For the first time ever, all of the Magnificent 7 stocks are live on-chain via Injective” to “redefine Wall Street and finance forever.”

According to the May 6 statement, Apple’s APPL, Microsoft’s MSFT, Amazon’s AMZN, Nvidia’s NVDA, Meta’s META, Google’s GOOGL, and Tesla’s TSLA are now “fully tradable 24/7 through Injective’s iAsset framework and the decentralized exchange Helix.

As of this writing, INJ trades at $9.25, a 27.2% increase in the monthly timeframe.

Featured Image from Unsplash.com, Chart from TradingView.com